Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil and Hyperthermia for Advanced Breast Cancer
NCT00006433Phase 2Unknown
- Sponsor
- National Center for Research Resources
- Start
- Jan 2000
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in breast cancer, sponsored by National Center for Research Resources. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00006433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006433.